Last reviewed · How we verify

NCT07185763

Nano-Learning for Improving Compliance Among Older Adults With Sarcopenia

Active, enrolled NA Last updated 22 September 2025
What this trial tests

NA trial testing Nano-Learning interventional program in Learning; Lack of (Specific) in 180 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
7 September 2025
Primary endpoint
20 January 2026
25 February 2026

Quick facts

Lead sponsorAlexandria University
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingsingle
Primary purposesupportive care
Enrollment180
Start date7 September 2025
Primary completion20 January 2026
Estimated completion25 February 2026
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Alexandria University

Who can join

Adults 58 to 75, any sex, with Learning; Lack of (Specific) or Depression. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Empirical evidence suggests that the use of short videos is associated with decreased feelings of loneliness and social isolation, thereby reducing depression among older adults . Platforms that allow users to showcase aspects of their own lives also serve as a significant avenue for achieving "happiness in old age" and enhancing social interactions with acquaintances . Therefore, this study aims to provide robust evidence on the effectiveness of nano-learning interventions, particularly in the context of sarcopenia, where addressing physical and psychological well-being has become increasingly critical among this cohort.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Alexandria University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07185763.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing